Granulocyte-macrophage colony-stimulating factor potentiates rituximab in patients with relapsed follicular lymphoma: results of a phase II study

PURPOSE: We hypothesized that granulocyte-macrophage colony-stimulating factor (GM-CSF) could potentiate the clinical activity of rituximab, given their individual and cooperative effects on FcγRIIa- and FcγRIIIa-expressing cells. A phase II clinical study combining GM-CSF and rituximab was initiate...

Full description

Saved in:
Bibliographic Details
Main Authors: Cartron, Guillaume, Zhao-Yang, Lu, Baudard, Marion, Kanouni, Tarik, Rouillé, Valérie, Quittet, Philippe, Klein, Bernard, Rossi, Jean-Francois
Format: Artigo
Language:Inglês
Published: American Society of Clinical Oncology 2008
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2443403/
https://ncbi.nlm.nih.gov/pubmed/18427151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2007.13.7729
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items